Considering the potential antifibrotic properties of BET inhibition, we investigated whether the BET inhibitor JQ1 can modulate fibrogenesis in an animal model of SSc, as well as in dermal fibroblasts isolated from patients with diffuse cutaneous SSc (dcSSc). Here, DNER is linked to systemic sclerosis.